HOOKIPA Pharma Inc. (HOOK) DCF Valuation
- ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
- ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
- ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
- ✓ No Se Necesita Experiencia; Fáciles De Seguir
HOOKIPA Pharma Inc. (HOOK) Bundle
Looking to assess the intrinsic value of HOOKIPA Pharma Inc.? Our HOOK DCF Calculator integrates real-world data with extensive customization features, enabling you to refine your forecasts and enhance your investment strategies.
Discounted Cash Flow (DCF) - (USD MM)
Year | AY1 2019 |
AY2 2020 |
AY3 2021 |
AY4 2022 |
AY5 2023 |
FY1 2024 |
FY2 2025 |
FY3 2026 |
FY4 2027 |
FY5 2028 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | 11.9 | 19.6 | 18.4 | 14.2 | 20.1 | 24.0 | 28.6 | 34.1 | 40.6 | 48.4 |
Revenue Growth, % | 0 | 63.99 | -5.8 | -22.76 | 41.27 | 19.17 | 19.17 | 19.17 | 19.17 | 19.17 |
EBITDA | -39.1 | -39.1 | -70.1 | -60.4 | -77.3 | -24.0 | -28.6 | -34.1 | -40.6 | -48.4 |
EBITDA, % | -327.36 | -199.89 | -380.13 | -423.86 | -384.24 | -100 | -100 | -100 | -100 | -100 |
Depreciation | 3.1 | 4.2 | 4.6 | 3.6 | 3.6 | 5.5 | 6.6 | 7.8 | 9.3 | 11.1 |
Depreciation, % | 25.68 | 21.19 | 25.15 | 25.28 | 17.65 | 22.99 | 22.99 | 22.99 | 22.99 | 22.99 |
EBIT | -42.2 | -43.3 | -74.8 | -64.0 | -80.9 | -24.0 | -28.6 | -34.1 | -40.6 | -48.4 |
EBIT, % | -353.04 | -221.08 | -405.28 | -449.14 | -401.88 | -100 | -100 | -100 | -100 | -100 |
Total Cash | 113.2 | 143.2 | 66.9 | 113.4 | 117.1 | 24.0 | 28.6 | 34.1 | 40.6 | 48.4 |
Total Cash, percent | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 | .0 |
Account Receivables | 9.7 | 20.7 | 21.2 | 22.0 | 19.3 | 22.9 | 27.3 | 32.5 | 38.8 | 46.2 |
Account Receivables, % | 81.45 | 105.48 | 114.73 | 154.48 | 95.74 | 95.44 | 95.44 | 95.44 | 95.44 | 95.44 |
Inventories | -8.2 | -15.5 | -15.3 | -.4 | .0 | -11.2 | -13.4 | -15.9 | -19.0 | -22.6 |
Inventories, % | -68.58 | -79.4 | -82.73 | -2.94 | 0 | -46.73 | -46.73 | -46.73 | -46.73 | -46.73 |
Accounts Payable | .9 | 8.0 | 8.8 | 5.5 | 12.5 | 9.4 | 11.3 | 13.4 | 16.0 | 19.1 |
Accounts Payable, % | 7.9 | 40.9 | 47.5 | 38.51 | 62.09 | 39.38 | 39.38 | 39.38 | 39.38 | 39.38 |
Capital Expenditure | -2.0 | -2.4 | -12.6 | -5.0 | -4.2 | -7.3 | -8.7 | -10.4 | -12.4 | -14.8 |
Capital Expenditure, % | -16.74 | -12.11 | -68.2 | -35.21 | -20.66 | -30.58 | -30.58 | -30.58 | -30.58 | -30.58 |
Tax Rate, % | -0.45314 | -0.45314 | -0.45314 | -0.45314 | -0.45314 | -0.45314 | -0.45314 | -0.45314 | -0.45314 | -0.45314 |
EBITAT | -42.2 | -43.3 | -74.8 | -64.0 | -81.3 | -24.0 | -28.6 | -34.1 | -40.6 | -48.4 |
Depreciation | ||||||||||
Changes in Account Receivables | ||||||||||
Changes in Inventories | ||||||||||
Changes in Accounts Payable | ||||||||||
Capital Expenditure | ||||||||||
UFCF | -41.7 | -38.0 | -82.8 | -84.4 | -72.5 | -21.3 | -31.2 | -37.2 | -44.3 | -52.8 |
WACC, % | 7.43 | 7.43 | 7.43 | 7.43 | 7.43 | 7.43 | 7.43 | 7.43 | 7.43 | 7.43 |
PV UFCF | ||||||||||
SUM PV UFCF | -146.9 | |||||||||
Long Term Growth Rate, % | 2.00 | |||||||||
Free cash flow (T + 1) | -54 | |||||||||
Terminal Value | -991 | |||||||||
Present Terminal Value | -692 | |||||||||
Enterprise Value | -839 | |||||||||
Net Debt | -111 | |||||||||
Equity Value | -729 | |||||||||
Diluted Shares Outstanding, MM | 9 | |||||||||
Equity Value Per Share | -77.11 |
What You Will Receive
- Comprehensive Financial Model: HOOKIPA Pharma Inc.’s actual data facilitates accurate DCF valuation.
- Complete Forecast Control: Modify revenue growth, profit margins, WACC, and other essential factors.
- Real-Time Calculations: Automatic updates provide immediate feedback as adjustments are made.
- Professional-Grade Template: A polished Excel file crafted for high-quality valuation presentations.
- Flexible and Reusable: Designed for adaptability, allowing for repeated applications in detailed forecasting.
Key Features
- Customizable Clinical Parameters: Adjust essential inputs such as trial success rates, market penetration, and R&D expenditures.
- Instant Valuation Calculations: Provides real-time insights into intrinsic value, NPV, and other financial metrics.
- High-Precision Analytics: Leverages HOOKIPA Pharma's actual financial data for credible valuation results.
- Effortless Scenario Testing: Easily evaluate various hypotheses and analyze their impacts side by side.
- Efficiency Booster: Streamlines the valuation process, removing the necessity for complex model construction.
How It Works
- Step 1: Download the prebuilt Excel template containing HOOKIPA Pharma Inc.'s (HOOK) data.
- Step 2: Navigate through the pre-filled sheets to familiarize yourself with the essential metrics.
- Step 3: Modify forecasts and assumptions in the editable yellow cells (WACC, growth, margins).
- Step 4: Instantly see the recalculated results, including HOOKIPA Pharma Inc.'s (HOOK) intrinsic value.
- Step 5: Make well-informed investment choices or create reports based on the outputs.
Why Choose This Calculator for HOOKIPA Pharma Inc. (HOOK)?
- Accurate Data: Utilize real HOOKIPA Pharma financials for trustworthy valuation outcomes.
- Customizable: Modify essential parameters such as growth rates, WACC, and tax rates to align with your forecasts.
- Time-Saving: Pre-configured calculations remove the hassle of starting from the ground up.
- Professional-Grade Tool: Tailored for investors, analysts, and consultants in the biotech sector.
- User-Friendly: Easy-to-navigate design and clear instructions ensure accessibility for all users.
Who Should Use HOOKIPA Pharma Inc. (HOOK)?
- Individual Investors: Gain insights to make informed decisions about investing in HOOKIPA Pharma Inc. stock.
- Financial Analysts: Enhance valuation methodologies with comprehensive financial models tailored for HOOK.
- Consultants: Provide clients with accurate and timely valuation analyses of HOOKIPA Pharma Inc.
- Business Owners: Learn how biotech companies like HOOKIPA are valued to inform your business strategies.
- Finance Students: Explore real-world valuation techniques using data from HOOKIPA Pharma Inc. and similar firms.
What the Template Contains
- Pre-Filled DCF Model: HOOKIPA Pharma Inc.’s financial data preloaded for immediate use.
- WACC Calculator: Detailed calculations for Weighted Average Cost of Capital.
- Financial Ratios: Evaluate HOOKIPA Pharma Inc.’s profitability, leverage, and efficiency.
- Editable Inputs: Change assumptions such as growth, margins, and CAPEX to fit your scenarios.
- Financial Statements: Annual and quarterly reports to support detailed analysis.
- Interactive Dashboard: Easily visualize key valuation metrics and results.